These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 88067)

  • 1. The extra-articular deposition of fibrinogen antigenic material in patients with rheumatoid arthritis.
    Danneskiold-Samsøe B; Clemmensen I; Andersen RB
    Scand J Rheumatol; 1979; 8(2):87-90. PubMed ID: 88067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen/fibrin degradation products in exudates from bullous dematoses.
    Mortensen T; Clemmensen I; Søndergaard J
    Acta Derm Venereol; 1979; 59(4):293-6. PubMed ID: 92141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinolytic activity of the blood and synovial fluid in patients with rheumatoid arthritis].
    Erov NK
    Ter Arkh; 1986; 58(7):73-7. PubMed ID: 2945279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid.
    Clemmensen I; Andersen RB
    J Lab Clin Med; 1978 Nov; 92(5):678-89. PubMed ID: 712203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of plasmin-resistant fibrinogen-fibrin breakdown products in rheumatoid synovial fluid by Brinastrase.
    Andersen RB; Gormsen J
    Scand J Rheumatol; 1973; 2(2):81-6. PubMed ID: 4270793
    [No Abstract]   [Full Text] [Related]  

  • 6. The primary plasmin inhibitor in rheumatoid synovial fluid.
    Clemmensen I; Donde R; Andersen RB
    Arthritis Rheum; 1977; 20(7):1354-8. PubMed ID: 143941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fibrinolytic system and its relation to inflammatory diseases.
    Clemmensen I; Andersen RB
    Semin Arthritis Rheum; 1982 May; 11(4):390-8. PubMed ID: 6179164
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of the common bile acids on the fibrin/fibrinogen fragments in rheumatoid synovial fluid. A possible clue to the ameliorating effect of jaundice in rheumatoid arthritis.
    Andersen RB; Bruusgaard A
    Scand J Rheumatol; 1975; 4(3):158-64. PubMed ID: 52191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
    Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of 19S antibodies and macroglobulin complexes from the synovial fluid in rheumatoid arthritis].
    Gay S; Geiler G
    Z Gesamte Inn Med; 1970 Jun; 25(11):496-500. PubMed ID: 5523393
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunodiffusion studies on synovial fluid from patients with rheumatoid arthritis: the reaction of fibrinogen with a streptococcal extract.
    Rylance HJ
    Ann Rheum Dis; 1978 Aug; 37(4):339-42. PubMed ID: 99093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selected indicators of blood coagulation and fibrinolysis in articular exudates of patients with rheumatoid arthritis].
    Dmoszyńska-Giannopoulou A; Kowalewski J; Pytko H; Szczepański L
    Reumatologia; 1979; 17(2):157-60. PubMed ID: 472525
    [No Abstract]   [Full Text] [Related]  

  • 13. Effector mechanisms and products of the physiological fibrinolytic systems.
    Edgington TS; Plow EF
    Prog Clin Biol Res; 1976; 5():85-120. PubMed ID: 61595
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.
    Zubler RH; Nydegger U; Perrin LH; Fehr K; McCormick J; Lambert PH; Miescher PA
    J Clin Invest; 1976 May; 57(5):1308-19. PubMed ID: 944196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases.
    Kummer JA; Abbink JJ; de Boer JP; Roem D; Nieuwenhuys EJ; Kamp AM; Swaak TJ; Hack CE
    Arthritis Rheum; 1992 Aug; 35(8):884-93. PubMed ID: 1379429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
    Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
    Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different molecular forms of fibronectin in rheumatoid synovial fluid.
    Clemmensen I; Andersen RB
    Arthritis Rheum; 1982 Jan; 25(1):25-31. PubMed ID: 7066034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
    Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
    Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.
    Tetta C; Camussi G; Modena V; Di Vittorio C; Baglioni C
    Ann Rheum Dis; 1990 Sep; 49(9):665-7. PubMed ID: 1700672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perturbation of protease inhibitors and substrates in inflammatory arthritis.
    Rothschild BM; Thompson LD; Pifer DD; Chesney CM
    Semin Thromb Hemost; 1985 Oct; 11(4):394-404. PubMed ID: 2416060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.